메뉴 건너뛰기




Volumn 16, Issue 1, 2007, Pages 3-5

Specialists versus generalists in the era of pay for performance: "A plague o' both your houses!"

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 33847410060     PISSN: 14753898     EISSN: None     Source Type: Journal    
DOI: 10.1136/qshc.2006.021006     Document Type: Note
Times cited : (7)

References (25)
  • 1
    • 0037080360 scopus 로고    scopus 로고
    • Profiling care provided by different groups of physicians: Effects of patient case-mix (bias) and physician-level clustering on quality assessment results
    • Greenfield S, Kaplan SH, Kahn R, et al. Profiling care provided by different groups of physicians: effects of patient case-mix (bias) and physician-level clustering on quality assessment results. Ann Intern Med 2002;136:111-21.
    • (2002) Ann Intern Med , vol.136 , pp. 111-121
    • Greenfield, S.1    Kaplan, S.H.2    Kahn, R.3
  • 2
    • 0036731347 scopus 로고    scopus 로고
    • Defining and understanding "co-management" care
    • Greenfield S. Defining and understanding "co-management" care. Diabetes Care 2002;25:1657-8.
    • (2002) Diabetes Care , vol.25 , pp. 1657-1658
    • Greenfield, S.1
  • 3
    • 33847358618 scopus 로고    scopus 로고
    • The effect of specialist care within the first year on subsequent outcomes in 24 232 adults with new-onset diabetes mellitus: Population-based cohort study
    • McAlister FA, Majumdar SR, Eurich DT, et al. The effect of specialist care within the first year on subsequent outcomes in 24 232 adults with new-onset diabetes mellitus: population-based cohort study. Qual Saf Health Care 2007;16:6-11.
    • (2007) Qual Saf Health Care , vol.16 , pp. 6-11
    • McAlister, F.A.1    Majumdar, S.R.2    Eurich, D.T.3
  • 4
    • 33645985193 scopus 로고    scopus 로고
    • Risk-adjusted mortality as an indicator of outcomes: Comparison of the Medicare Advantage Program with the Veterans' Health Administration
    • Selim AJ, Kazis LE, Rogers W, et al. Risk-adjusted mortality as an indicator of outcomes: comparison of the Medicare Advantage Program with the Veterans' Health Administration. Med Care 2006;44:359-65.
    • (2006) Med Care , vol.44 , pp. 359-365
    • Selim, A.J.1    Kazis, L.E.2    Rogers, W.3
  • 5
    • 0034700790 scopus 로고    scopus 로고
    • Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
    • Heart Outcomes Prevention Evaluation Study Investigators
    • Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9.
    • (2000) Lancet , vol.355 , pp. 253-259
  • 6
    • 0037840242 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol-lowering with simvostatin in 5963 people with diabetes: A randomised placebo-controlled trial
    • Collins R, Armitage J, Parish S, et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvostatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-16.
    • (2003) Lancet , vol.361 , pp. 2005-2016
    • Collins, R.1    Armitage, J.2    Parish, S.3
  • 7
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group
    • Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3
  • 8
    • 33847383067 scopus 로고    scopus 로고
    • Available at, accessed October 2006
    • The National Quality Forum. Available at http://www.qualityforum. org (accessed October 2006).
  • 9
    • 33847393791 scopus 로고    scopus 로고
    • Ambulatory Care Quality Alliance. Available at http://www.acponline.org/revitalization/starter_set.pdf (accessed October 2006).
    • Ambulatory Care Quality Alliance. Available at http://www.acponline.org/revitalization/starter_set.pdf (accessed October 2006).
  • 11
    • 32144448938 scopus 로고    scopus 로고
    • Standards of medical care for patients with diabetes mellitus
    • American Diabetes Association, Available at, accessed October 2006
    • American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2006;29: S4-S42, Available at http://care.diabetesjournals.org/content/vol29/suppl_1/ (accessed October 2006).
    • (2006) Diabetes Care , vol.29
  • 12
    • 33847414244 scopus 로고    scopus 로고
    • National Committee for Quality Assurance, Washington DC
    • National Committee for Quality Assurance. HEDIS 2007 Volume 2, Technical Manual, Washington DC, 2006.
    • (2006) HEDIS 2007 Volume 2, Technical Manual
  • 13
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group
    • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 14
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 15
    • 33750135569 scopus 로고    scopus 로고
    • Narrative review: Lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem
    • Hayward RA, Hofer TP, Vijan S. Narrative review: Lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Int Med 2006;145:520-30.
    • (2006) Ann Int Med , vol.145 , pp. 520-530
    • Hayward, R.A.1    Hofer, T.P.2    Vijan, S.3
  • 16
    • 33847370918 scopus 로고    scopus 로고
    • California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes, Available at, accessed October 2000
    • California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus, Available at http://www.americangeriatrics.org/products/positionpapers/JAGSfinal05.pdf (accessed October 2000).
    • Guidelines for improving the care of the older person with diabetes mellitus
  • 18
    • 0034232349 scopus 로고    scopus 로고
    • Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control
    • Gavin LA, Barth J, Arnold D, et al. Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control. Endocr Pract 2000;6:305-10.
    • (2000) Endocr Pract , vol.6 , pp. 305-310
    • Gavin, L.A.1    Barth, J.2    Arnold, D.3
  • 19
    • 15944382350 scopus 로고    scopus 로고
    • Reduced hypoglycemia risk with insulin glargine: A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes
    • Rosenstock J, Dailey G, Massi-Benedelti M, et al. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 2005;28:950-5.
    • (2005) Diabetes Care , vol.28 , pp. 950-955
    • Rosenstock, J.1    Dailey, G.2    Massi-Benedelti, M.3
  • 20
    • 0036863587 scopus 로고    scopus 로고
    • Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    • Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393-404.
    • (2002) J Clin Hypertens (Greenwich) , vol.4 , pp. 393-404
    • Cushman, W.C.1    Ford, C.E.2    Cutler, J.A.3
  • 21
    • 33746433601 scopus 로고    scopus 로고
    • Effects of quality improvement strategies for type 2 diabetes on glycemic control: A meta-regression analysis
    • Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006;296:427-40.
    • (2006) JAMA , vol.296 , pp. 427-440
    • Shojania, K.G.1    Ranji, S.R.2    McDonald, K.M.3
  • 22
    • 10744228815 scopus 로고    scopus 로고
    • Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension: Results or a randomized controlled trial
    • Murray MD, Harris LE, Overhage JM, et al. Failure of computerized treatment suggestions to improve health outcomes of outpatients with uncomplicated hypertension: results or a randomized controlled trial. Pharmacotherapy 2004;24:324-37.
    • (2004) Pharmacotherapy , vol.24 , pp. 324-337
    • Murray, M.D.1    Harris, L.E.2    Overhage, J.M.3
  • 23
    • 33646349240 scopus 로고    scopus 로고
    • Aligning performance measurement with clinical epidemiology: Comparison of weighted performance measurement and dichotomous thresholds for glycemic control in the Veterans Health Administration
    • Pogach LM, Rajan M, Aron DC. Aligning performance measurement with clinical epidemiology: comparison of weighted performance measurement and dichotomous thresholds for glycemic control in the Veterans Health Administration. Diabetes Care 2006;29:241-6.
    • (2006) Diabetes Care , vol.29 , pp. 241-246
    • Pogach, L.M.1    Rajan, M.2    Aron, D.C.3
  • 24
    • 33645823854 scopus 로고    scopus 로고
    • Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002
    • Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 2006;144:465-74.
    • (2006) Ann Intern Med , vol.144 , pp. 465-474
    • Saaddine, J.B.1    Cadwell, B.2    Gregg, E.W.3
  • 25
    • 33645826018 scopus 로고    scopus 로고
    • Improving the outcomes of metabolic conditions: Managing momentum to overcome clinical inertia
    • Perlin JB, Pogach LM. Improving the outcomes of metabolic conditions: managing momentum to overcome clinical inertia. Ann Intern Med 2006;144:525-7.
    • (2006) Ann Intern Med , vol.144 , pp. 525-527
    • Perlin, J.B.1    Pogach, L.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.